Brief: Bcal Diagnostics Secures A$4.9 Million Under Convertible Note Facility
29/06/2026 02:27
BRIEF-Bcal Diagnostics Secures A$4.9 Million Under Convertible Note Facility June 29 (Reuters) - BCAL Diagnostics Ltd BDX.AX:
SECURES A$4.9 MILLION UNDER CONVERTIBLE NOTE FACILITY
EXPECTS REMAINING FY26 RD TAX OFFSET IN OCTOBER 2026
Further company coverage: BDX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BCAL Diagnostics
See all newsAustralia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise
Brief: BCAL Diagnostics Introduces Avantect Multi-Cancer Early Detection Test
Brief: BCAL Diagnostics Clarifies Of Bcal's Position In Relation To Genetic Signatures
Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Brief: BCAL To Acquire Shares In Genetic Signatures